BEGIN:VCALENDAR
PRODID:-//AddEvent Inc//AddEvent.com v1.7//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:STANDARD
DTSTART:20221030T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20220327T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20220811T121720Z
STATUS:CONFIRMED
UID:1660220240addeventcom
SEQUENCE:0
DTSTART;TZID=Europe/Madrid:20220910T161500
DTEND;TZID=Europe/Madrid:20220910T171500
SUMMARY:FS 605 – HCC - changing the therapy paradigm?
DESCRIPTION:Title: FS 605 – HCC - changing the therapy paradigm?\n\nType: Focus Session\n\nTopics: Interventional Oncology\n\n2022\, September 10 | 16:15 - 17:15 (Europe/Madrid)\nAuditorium 2\n\nScheduled lectures:\n\n605.1 / Surgery/LTx versus thermal ablation in early HCC\n- M. Meijerink\n\n605.2 / Transarterial therapy versus immunotherapy in intermediate HCC\n- I. Bargellini\n\n605.3 / Immunotherapy versus transarterial therapy in advanced HCC\n- T. de Baere\n\n605.4 / Early combination therapies versus stepwise therapy sequences\n- P. Pereira\n\nVisit https://programme.cirse2022.cirse.org to watch live and on demand!
X-ALT-DESC;FMTTYPE=text/html:Title: FS 605 – HCC - changing the therapy paradigm?
Type: Focus Session
Topics: Interventional Oncology
2022, September 10 | 16:15 - 17:15 (Europe/Madrid)
Auditorium 2
Scheduled lectures:
605.1 / Surgery/LTx versus thermal ablation in early HCC
- M. Meijerink
605.2 / Transarterial therapy versus immunotherapy in intermediate HCC
- I. Bargellini
605.3 / Immunotherapy versus transarterial therapy in advanced HCC
- T. de Baere
605.4 / Early combination therapies versus stepwise therapy sequences
- P. Pereira
Visit https://programme.cirse2022.cirse.org to watch live and on demand!
LOCATION:Auditorium 2
TRANSP:OPAQUE
END:VEVENT
END:VCALENDAR